The 36-month CORE-VNS study findings showed sustained seizure reduction, improved quality of life, and reduced seizure-related hospitalizations among people with drug-resistant epilepsy receiving vagus nerve stimulation therapy.
|Poll|January 6, 2015
Yellow Cerebrospinal Fluid
Author(s)Figure1
Listen
0:00 / 0:00
Key Takeaways
- Status epilepticus in HIV-positive patients can result from opportunistic infections, neoplasms, or metabolic disturbances.
- CSF analysis is crucial for identifying the underlying cause of neurological symptoms in HIV-positive individuals.
This yellow CSF was drawn from an HIV-positive man who presented with status epilepticus. What is the most likely cause?
Advertisement
This CSF was drawn from a 26 year-old HIV-positive male who presented with status epilepticus.
What do you suspect is the cause?
Advertisement
Related to this article
Here's some of what is coming soon to NeurologyLive® this week.
Newly presented post hoc analyses examined diazepam nasal spray for status epilepticus in seizure clusters and intervals between clusters in children, alongside real-world data on rescue medication prescribing.
A retrospective 10-center U.S. study found stiripentol reduced convulsive seizure frequency, status epilepticus episodes, and emergency health care use in patients with Dravet syndrome.
A phase 1b/2 trial is testing an intrathecal antisense oligonucleotide designed to lower KCNT1 expression in children with a severe, drug-resistant epilepsy syndrome.
Here's some of what is coming soon to NeurologyLive® this week.
Terry Livingston, PharmD, vice president of medical affairs at Octave Bioscience, discussed the evolving role of blood-based biomarkers in multiple sclerosis care.
New biomarker data showed smaller post-onset increases in plasma neurofilament light chain and glial fibrillary acidic protein with privosegtor added to steroids in patients with acute optic neuritis.
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Remibrutinib Lowers Relapse Rate vs Teriflunomide in Relapsing MS
2
FDA Accepts Troriluzole NDA Resubmission for Spinocerebellar Ataxia
3
Tenecteplase Benefit Before Thrombectomy Varies by Stroke Cause, Study Shows
4
Phase 2 ACUITY Analysis Shows Privosegtor Associated With Smaller Early NfL and GFAP Increases in Acute Optic Neuritis
5